Annals ofTransplants

Volume: 4 - Number: 27 - February 15, 2006

Outstanding

Who will regulate the regulators?

Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia

Allografting

Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia

Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome

Clinical investigations and reports

Simvastatin Initiated Early After Heart Transplantation: 8-Year Prospective Experience

Conditioning Regimens

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party

Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies

Editorial

Who will regulate the regulators?

Graft Versus Tumor Effects

Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease

In Vitro Studies

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma

Post-Transplant Events

Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

Recovery of V24+ NKT cells after hematopoietic stem cell transplantation

Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?

Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-1 and cyclooxygenase-2

Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome

Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children

Review

Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation